PlasticsEurope Deutschland e.V.
Trending: Pharmaceuticals & Science
-
Media:
All
- Period:
- Period:Total
- more
Legalization turns Germany into a cannabis hotspot: Mary Jane becomes the world’s largest cannabis trade fair for the first time /500 international exhibitors and 60,000 visitors expected in Berlin – boom in medical cannabis
Berlin (ots) - About a year after partial legalization by the “traffic light” government coalition, Germany has become the key meeting point for the global cannabis scene. With 60,000 expected visitors, over 500 exhibitors, and an expanded festival area, Mary Jane Berlin will – for the first time since its ...
moreHorizon3.ai Raises $100M to Cement Leadership in Autonomous Security
London (ots) - - “The future of cybersecurity is AI vs. AI, and Horizon3.ai is leading the way,” said Snehal Antani, CEO and Co-Founder of Horizon3.ai. - The new funding will be used to strengthen Horizon3.ai’s leadership in autonomous cybersecurity. - Interview requests with Snehal Antani: Please contact team@euromarcom.com to arrange an interview. Horizon3.ai, the company behind the NodeZero® Autonomous Security ...
moreBIAL Announces Oral Presentation at GBA1 Meeting 2025
Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...
moreGrünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia
Aachen, Germany (ots) - - Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America. - As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile. - Since 2017, ...
moreMaren Thurow starts as new Head Global Communications at Grünenthal
more
Infineon gains approval of Science Based Targets initiative for ambitious CO2 emission reduction targets
moreNeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response
Heidelberg, Germany, Milan, Seville, Spain and Binyamina, Israel (ots/PRNewswire) - A European-led consortium comprising Heidelberg University Hospital (UKHD), the European Institute of Oncology (IEO), Virgen Macarena University Hospital, and OncoHost today announced that it has been awarded a €2.5 million grant ...
moreNTT DATA Business Solutions AG
2New record achieved: NTT DATA Business Solutions exceeds the previous year’s top figures in terms of both revenue and results
moreNew Executive Management Board at Bender - the world's leading provider of solutions that make electrical infrastructures smart and safer
moreColt Data Centre Services (Colt DCS)
Colt DCS appoints Xavier Matagne as Chief Real Estate Officer - Matagne to drive further growth of Colt DCS towards 1GW of data centre capacity
London (ots/PRNewswire) - Colt Data Centre Services (Colt DCS), global provider of hyperscale and large enterprise data centre facilities, today announced the appointment of Xavier Matagne to the role of Chief Real Estate Officer. Matagne will be responsible for leading Colt DCS' Development, Engineering and ...
moreAnalytic Partners Shapes Marketing Mix Modeling (MMM) for 25 years and Innovates with Commercial Analytics
Miami (ots/PRNewswire) - Analytic Partners celebrates 25 years with a new website announcing a renewed push to elevate MMM and MTA measurement programs to deliver Commercial Intelligence. Analytic Partners has enjoyed a long history of consistent, organic growth over its 25 years, becoming a recognized leader in the ...
more
Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site
moreAnnual Report 2024 released by Scantox Group
Ejby, Denmark (ots/PRNewswire) - Scantox Group has released their 2024 Annual Report today. It highlights the many activities the company has done over the year to shape the future of a business that in so many ways contribute to improve lives worldwide through the development of new drugs and treatments. "Our 2024 result shows high profitable growth from transformational acquisitions. We are very pleased with these ...
moreCentor Launches Smart Pill Organizer to Support Medication Adherence
moreFinancial Year 2024: Weleda Achieves Record Turnover and Significantly Improves Profitability
moreData4Life releases Data2Evidence as open source: a new chapter for global health research
moreFox ESS Achieves A-Rating in 2025 HTW Berlin Energy Storage Inspection
more
Xella achieves significant progress in CO2 emissions reduction, circular economy, and occupational safety
moreInfineon strengthens its position as innovation driver in the semiconductor industry in India with new R&D hub
more- 2
Exceptional Partnership: Princess Madeleine and Weleda Launch New Skincare Brand, minLen
more Weleda Unveils Its First Comprehensive Modernization of the Brand Appearance in over 100 Years
moreREPCHANCE Europe Study Reveals Persistent Underrepresentation of Immigrant-Origin MPs Across Key European Countries
Berlin/Stuttgart (ots) - - Immigrant-origin populations remain underrepresented in the national parliaments of Germany, the Netherlands, Spain, Switzerland, and the UK, with the Netherlands having the highest share (19%) and Spain the lowest (2%). - While representation has increased over the last decade ...
moreInfineon and Automotive Research Association of India collaborate to advance automotive semiconductor solutions
more
ZEISS Research Microscopy Solutions
ZEISS Lightfield 4D for instant volumetric high-speed imaging / Capturing physiological and neuronal processes in 3D
moreApotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
Aachen, Germany & Toronto, Canada, (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, ...
moreInfineon teams up with Thailand Science Research and Innovation to drive innovation ecosystem in Thailand
moreEU4Regions - How EU cohesion policy solves local challenges and strengthens cross-border cooperation
Brussels (ots) - A new project is being launched to promote the European Union’s cohesion policy aimed at strengthening economic, social and territorial unity across the continent’s regions. The ‘EU4Regions’ project will create comprehensive multimedia and journalistic content that makes the impact of the ...
moreE-Fuel producer INERATEC has received a funding commitment of €70 million from the European Investment Bank and Breakthrough Energy Catalyst
moreX4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.
London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...
more